
-
4.12.22-Health-Science-Startups-CellChorus
CellChorus - July 26, 2019 | MIT News Office
Scientists look to synthetic biology and 3-D printing for life support in space
- Tue, April 12, 2022 | Conference
2022 MIT Health Science Technologies Conference - Startup Exchange Lightning Talks
Boston Marriott CambridgeStartup Lightning Talks - 2022 MIT Health Science Technologies Conference
The Future of Cell & Gene Therapies - Tue, April 4, 2023 | Conference
2023 MIT Health Science Technology Conference - Startup Exchange Lightning Talks
Boston Marriott CambridgeThis conference will explore new or improved therapeutic approaches for finding cures for diseases which traditionally have been difficult to treat. This includes technologies for optimizing treatments and monitoring efficacy based on insights into cell and tissue state, circuitry, behavior, function, and responsiveness in normal and disease states, biomarker detection, better methods to predict and track efficacy, and enhanced manufacturing capabilities.
-
Past Deadline: Feb 17, 2022
Leading industrial pump manufacturer seeking early stage technology to commercialize
partnershipIngersoll Rand is seeking early stage technology to commercialize, with the aim of yielding more data connectivity and performance for productivity, efficiency, and sustainability improvements.
-
04.30.24-Startup-Ecosystem-Conference-Fireside-Chat-Investing-in-Science-Based-Startups
Investing in Science Based Startups
-
4.12.22-Health-Science-Startups-Tevard-Biosciences
Tevard Biosciences -
4.12.22-Health-Science-Startups-Multiply-Labs
Multiply Labs
-
4.12.22-Health-Science-Startups-Kano-Therapeutics
Floris Engelhardt
CEO, Kano Therapeutics